Drug Profile
DTaP poliovirus vaccine - GSK
Alternative Names: Boostrix Polio; Boostrix-IPV; DTaP-poliovirus vaccine adult - GSKLatest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Bacterial vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diphtheria; Pertussis; Poliomyelitis; Tetanus
Most Recent Events
- 01 Mar 2012 GlaxoSmithKline completes the phase IV trial in Diphtheria, Pertussis, Poliomyelitis, Tetanus in France and Germany (IM) (NCT01323959)
- 06 Jan 2006 Registered for Diphtheria in India (IM)
- 06 Jan 2006 Registered for Pertussis in India (IM)